0 Evaluaciones
ID

37354

Descripción

Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form contains details on the administration of the investigational product and is to be filled in at Day 1, 2 and 3. Additionally, this form also contains Randomisation information and the assignment of the participant to one of the four cohorts for/prior to the first medication administration.

Link

https://clinicaltrials.gov/ct2/show/NCT00996840

Palabras clave

Versiones (2)
  1. 16/7/19 16/7/19 -
  2. 20/7/19 20/7/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

20 de julio de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    SB-681323 in ALI/ARDS risk patients - NCT00996840

    Inglés

    Investigational Product - IV Dosing, Randomisation, Cohort Assignment

    1 formularios  
    Administrative Data
    Descripción

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722
    Subject ID
    Descripción

    Subject ID

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Date of Visit
    Descripción

    please fill in the form for each of the three study days

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C1320303
    Which Cohort is the subject enrolled in?
    Descripción

    Please ensure the Cohort selected is correct before submitting. Medication is infused over 4 or 24 hours depending on the cohort.

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C0599755
    Date/Time of Cohort Assignment
    Descripción

    Date/Time of Cohort Assignment

    Tipo de datos

    datetime

    Alias
    UMLS CUI [1,1]
    C0599755
    UMLS CUI [1,2]
    C1516050
    UMLS CUI [1,3]
    C1264639
    First Administration
    Descripción

    First Administration

    Alias
    UMLS CUI-1
    C3469597
    Dosage Duration (per Protocol)
    Descripción

    Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24hrs

    Tipo de datos

    integer

    Alias
    UMLS CUI [1,1]
    C0449238
    UMLS CUI [1,2]
    C3469597
    UMLS CUI [1,3]
    C0304229
    Start Date and Time
    Descripción

    Start Date and Time

    Tipo de datos

    datetime

    Alias
    UMLS CUI [1]
    C3897500
    Stop Date and Time
    Descripción

    Stop Date and Time

    Tipo de datos

    datetime

    Alias
    UMLS CUI [1]
    C3899266
    Volume administered (mL)
    Descripción

    Volume administered

    Tipo de datos

    float

    Unidades de medida
    • mL
    Alias
    UMLS CUI [1]
    C2349139
    mL
    Administration post interruption
    Descripción

    Administration post interruption

    Alias
    UMLS CUI-1
    C3469597
    UMLS CUI-2
    C0687676
    UMLS CUI-3
    C1512900
    Dosage Duration (per Protocol)
    Descripción

    Cohorts 1/3: 0-4 hrs Cohorts 2/4: 0-24 hrs

    Tipo de datos

    integer

    Alias
    UMLS CUI [1,1]
    C0449238
    UMLS CUI [1,2]
    C3469597
    UMLS CUI [1,3]
    C0304229
    Start Date and Time
    Descripción

    Start Date and Time

    Tipo de datos

    datetime

    Alias
    UMLS CUI [1]
    C3897500
    Stop Date and Time
    Descripción

    Stop Date and Time

    Tipo de datos

    datetime

    Alias
    UMLS CUI [1]
    C3899266
    Volume administered (mL)
    Descripción

    Volume administered

    Tipo de datos

    float

    Unidades de medida
    • mL
    Alias
    UMLS CUI [1]
    C2349139
    mL
    Investigational Product Container Number
    Descripción

    Investigational Product Container Number

    Alias
    UMLS CUI-1
    C0304229
    UMLS CUI-2
    C0180098
    UMLS CUI-3
    C0600091
    Investigational Product Container Number
    Descripción

    Record the identifying number from the investigational product container dispensed at this visit

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C0180098
    UMLS CUI [1,3]
    C0600091
    Treatment Confirmation
    Descripción

    Treatment Confirmation

    Alias
    UMLS CUI-1
    C0750484
    UMLS CUI-2
    C0087111
    Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
    Descripción

    If no, record reasons

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0087111
    UMLS CUI [1,2]
    C2349182
    Reason incorrect treatment
    Descripción

    if applicable

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0566251
    UMLS CUI [1,2]
    C0087111
    UMLS CUI [1,3]
    C3827420
    Randomisation Number
    Descripción

    Randomisation Number

    Alias
    UMLS CUI-1
    C0034656
    UMLS CUI-2
    C0237753
    Was the subject able to be randomised?
    Descripción

    If yes, provide Randomisation Number and Date/time of randomisation

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0034656
    UMLS CUI [1,2]
    C0332149
    Randomisation Number
    Descripción

    if applicable

    Tipo de datos

    integer

    Alias
    UMLS CUI [1,1]
    C0034656
    UMLS CUI [1,2]
    C0237753
    Date/time of randomisation
    Descripción

    if applicable

    Tipo de datos

    datetime

    Alias
    UMLS CUI [1,1]
    C0034656
    UMLS CUI [1,2]
    C1264639
    Volver a la parte superior de la página

    Similar models

    Investigational Product - IV Dosing, Randomisation, Cohort Assignment

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    Subject ID
    Item
    Subject ID
    integer
    C2348585 (UMLS CUI [1])
    Item
    Date of Visit
    integer
    C1320303 (UMLS CUI [1])
    Date of Visit
    Code List
    Date of Visit
    CL Item
    Day 1 (1)
    CL Item
    Day 2 (2)
    CL Item
    Day 3 (3)
    Item
    Which Cohort is the subject enrolled in?
    text
    C0599755 (UMLS CUI [1])
    Cohort
    Code List
    Which Cohort is the subject enrolled in?
    CL Item
    Cohort 1 (3mg/Placebo IV / 4hrs) (C1)
    CL Item
    Cohort 2 (7.5mg/Placebo IV / 24hrs) (C2)
    CL Item
    Cohort 3 (7.5mg/Placebo IV / 4hrs) (C3)
    CL Item
    Cohort 4 (10mg/Placebo IV / 24hrs) (C4)
    Date/Time of Cohort Assignment
    Item
    Date/Time of Cohort Assignment
    datetime
    C0599755 (UMLS CUI [1,1])
    C1516050 (UMLS CUI [1,2])
    C1264639 (UMLS CUI [1,3])
    Item Group
    First Administration
    C3469597 (UMLS CUI-1)
    Item
    Dosage Duration (per Protocol)
    integer
    C0449238 (UMLS CUI [1,1])
    C3469597 (UMLS CUI [1,2])
    C0304229 (UMLS CUI [1,3])
    Dosage Duration
    Code List
    Dosage Duration (per Protocol)
    CL Item
    0-4 hrs (1)
    CL Item
    0-24 hrs (2)
    Start Date and Time
    Item
    Start Date and Time
    datetime
    C3897500 (UMLS CUI [1])
    Stop Date and Time
    Item
    Stop Date and Time
    datetime
    C3899266 (UMLS CUI [1])
    Volume administered
    Item
    Volume administered (mL)
    float
    C2349139 (UMLS CUI [1])
    Item Group
    Administration post interruption
    C3469597 (UMLS CUI-1)
    C0687676 (UMLS CUI-2)
    C1512900 (UMLS CUI-3)
    Item
    Dosage Duration (per Protocol)
    integer
    C0449238 (UMLS CUI [1,1])
    C3469597 (UMLS CUI [1,2])
    C0304229 (UMLS CUI [1,3])
    Dosage Duration
    Code List
    Dosage Duration (per Protocol)
    CL Item
    0-4 hrs (1)
    CL Item
    0-24 hrs (2)
    Start Date and Time
    Item
    Start Date and Time
    datetime
    C3897500 (UMLS CUI [1])
    Stop Date and Time
    Item
    Stop Date and Time
    datetime
    C3899266 (UMLS CUI [1])
    Volume administered
    Item
    Volume administered (mL)
    float
    C2349139 (UMLS CUI [1])
    Item Group
    Investigational Product Container Number
    C0304229 (UMLS CUI-1)
    C0180098 (UMLS CUI-2)
    C0600091 (UMLS CUI-3)
    Investigational Product Container Number
    Item
    Investigational Product Container Number
    text
    C0304229 (UMLS CUI [1,1])
    C0180098 (UMLS CUI [1,2])
    C0600091 (UMLS CUI [1,3])
    Item Group
    Treatment Confirmation
    C0750484 (UMLS CUI-1)
    C0087111 (UMLS CUI-2)
    Correct treatment received
    Item
    Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
    boolean
    C0087111 (UMLS CUI [1,1])
    C2349182 (UMLS CUI [1,2])
    Reason incorrect treatment
    Item
    Reason incorrect treatment
    text
    C0566251 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    C3827420 (UMLS CUI [1,3])
    Item Group
    Randomisation Number
    C0034656 (UMLS CUI-1)
    C0237753 (UMLS CUI-2)
    Randomisation possible
    Item
    Was the subject able to be randomised?
    boolean
    C0034656 (UMLS CUI [1,1])
    C0332149 (UMLS CUI [1,2])
    Randomisation Number
    Item
    Randomisation Number
    integer
    C0034656 (UMLS CUI [1,1])
    C0237753 (UMLS CUI [1,2])
    Randomisation Date/Time
    Item
    Date/time of randomisation
    datetime
    C0034656 (UMLS CUI [1,1])
    C1264639 (UMLS CUI [1,2])
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial